Detection of kaposi sarcoma-associated herpesvirus DNA in saliva and buffy-coat samples from children with sickle cell disease in Uganda
- PMID: 15378429
- DOI: 10.1086/424489
Detection of kaposi sarcoma-associated herpesvirus DNA in saliva and buffy-coat samples from children with sickle cell disease in Uganda
Abstract
Among 233 children, Kaposi sarcoma-associated herpesvirus (KSHV) DNA was detected in 43% of children seropositive for both K8.1 and orf73, in 29% of children seropositive for K8.1 only, in 14% of children seropositive for orf73 only, and in 7% of children seronegative for both K8.1 and orf73; among 228 mothers, KSHV DNA was detected in 27%, 25%, 4%, and 1%, respectively. KSHV DNA was detected more frequently and at higher levels in saliva than in buffy-coat samples and in children than in mothers. In both children and mothers, detection in saliva was associated with detection in peripheral blood. Detection was associated with K8.1 seropositivity, younger age, and high household density, indicating the importance of in-household person-to-person transmission, likely via saliva.
Copyright 2004 Infectious Diseases Society of America
Similar articles
-
Distribution of Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 in maternal saliva and breast milk in Zambia: implications for transmission.J Infect Dis. 2004 Jun 15;189(12):2260-70. doi: 10.1086/421119. Epub 2004 May 25. J Infect Dis. 2004. PMID: 15181574
-
Influence of HLA alleles on shedding of Kaposi sarcoma-associated herpesvirus in saliva in an African population.J Infect Dis. 2007 Mar 15;195(6):809-16. doi: 10.1086/511827. Epub 2007 Feb 5. J Infect Dis. 2007. PMID: 17299710
-
Mother-to-child transmission of human herpesvirus-8 in South Africa.J Infect Dis. 2004 Sep 15;190(6):1068-75. doi: 10.1086/423326. Epub 2004 Aug 11. J Infect Dis. 2004. PMID: 15319855
-
Kaposi's sarcoma-associated herpesvirus transmission and primary infection.Curr Opin HIV AIDS. 2009 Jan;4(1):22-6. doi: 10.1097/COH.0b013e32831add5a. Curr Opin HIV AIDS. 2009. PMID: 19339936 Review.
-
Human herpesvirus 8 epidemiology: what we do and do not know.AIDS. 2003 Aug 15;17(12):1717-30. doi: 10.1097/01.aids.0000076337.42412.86. AIDS. 2003. PMID: 12891058 Review. No abstract available.
Cited by
-
Prevalence and predictors of kaposi sarcoma herpes virus seropositivity: a cross-sectional analysis of HIV-infected adults initiating ART in Johannesburg, South Africa.Infect Agent Cancer. 2011 Nov 17;6:22. doi: 10.1186/1750-9378-6-22. Infect Agent Cancer. 2011. PMID: 22093140 Free PMC article.
-
Risk factors for seropositivity to Kaposi sarcoma-associated herpesvirus among children in Uganda.J Acquir Immune Defic Syndr. 2013 Jun 1;63(2):228-33. doi: 10.1097/QAI.0b013e31828a7056. J Acquir Immune Defic Syndr. 2013. PMID: 23403859 Free PMC article.
-
Kaposi's sarcoma-associated herpesvirus seropositivity is associated with parasite infections in Ugandan fishing communities on Lake Victoria islands.PLoS Negl Trop Dis. 2019 Oct 16;13(10):e0007776. doi: 10.1371/journal.pntd.0007776. eCollection 2019 Oct. PLoS Negl Trop Dis. 2019. PMID: 31618208 Free PMC article.
-
Genome evolution of Kaposi sarcoma-associated herpesvirus (KSHV).J Virol. 2025 May 20;99(5):e0195024. doi: 10.1128/jvi.01950-24. Epub 2025 Apr 16. J Virol. 2025. PMID: 40237497 Free PMC article.
-
BALB/c mice immunized with a combination of virus-like particles incorporating Kaposi sarcoma-associated herpesvirus (KSHV) envelope glycoproteins gpK8.1, gB, and gH/gL induced comparable serum neutralizing antibody activity to UV-inactivated KSHV.Oncotarget. 2017 May 23;8(21):34481-34497. doi: 10.18632/oncotarget.15605. Oncotarget. 2017. PMID: 28404899 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials